A new Omicron variant is quickly spreading through the United States. A new Congressional report finds irregularities with the FDA’s accelerated approval for the Alzheimer’s drug Adulhelm. And, medical bill disputes between payers and providers are overwhelming the resolution system set up following the No Surprises Act. That's coming up on today's episode of Gist Healthcare Daily.

Hosted on Acast. See acast.com/privacy for more information.